Company / SG&A per Share
West Pharmaceutical Services SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$5.44
FY2025
5-year range
$3.69 / $5.44
FY2021-FY2025
Trend
+18.2%
vs FY2024
Sector context
#82 of 156
Health Care
What the data says
At $5.44, West Pharmaceutical Services's sg&a per share ranks #75 of 156 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $3.16 in FY2016 to $5.44 in FY2025.
Based on SEC 10-K filings.
5.44 in FY2025 with a 5-year CAGR of +8.9%.
Increased from $4.77 to $5.44 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +10.2%
- 5-Year CAGR
- +8.9%
- 10-Year CAGR
- -
Sector benchmark
#75 of 156 in Health CareTop 47% of 156This company $5.44 Sector average $11421.56
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 18.2% year-over-year.
- Ranks #82 out of 156 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.44 | +18.2% |
| FY2024 | $4.61 | -3.4% |
| FY2023 | $4.77 | +17.2% |
| FY2022 | $4.07 | +10.4% |
| FY2021 | $3.69 | +3.9% |
| FY2020 | $3.55 | -3.6% |
| FY2019 | $3.68 | +3.4% |
| FY2018 | $3.56 | +5.7% |
| FY2017 | $3.37 | +6.4% |
| FY2016 | $3.16 | -4.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026